Literature DB >> 11805588

Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women.

Celine M Vachon1, Pamela J Mink, Carol A Janney, Thomas A Sellers, James R Cerhan, Lynn Hartmann, Aaron R Folsom.   

Abstract

Although parity is associated with a decreased risk of ovarian cancer in the general population, this association among women with a family history is less clear. We examined this question in a prospective cohort of 31,377 Iowa women 55-69 years of age at baseline. Relative risks (RRs) and 95% confidence intervals (CIs) were estimated through Cox regression. We identified 181 incident epithelial ovarian cancers through 13 years of follow-up. At baseline, 14% of the women reported breast or ovarian cancer in a first-degree relative, and an additional 12% reported a family history in a second-degree relative. Among women without a family history of breast or ovarian cancer in a first-degree relative, nulliparous women were at slightly increased risk of ovarian cancer (RR = 1.4, 95% CI = 0.9-2.4) compared with parous women, whereas among women with a family history, nulliparous women were at a much higher risk (RR = 2.7, 95% CI = 1.1-6.6) than parous women. Similar results were seen when family history included first- or second-degree relatives with breast or ovarian cancer or a first- or second-degree relative with ovarian cancer only. Nulliparity may be more strongly associated with an increased risk of ovarian cancer among women with a family history of breast or ovarian cancer, compared with women who do not have a family history of those cancers.

Entities:  

Mesh:

Year:  2002        PMID: 11805588     DOI: 10.1097/00001648-200201000-00011

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  11 in total

Review 1.  Use of fertility drugs and risk of ovarian cancer.

Authors:  Brenda Diergaarde; Michelle L Kurta
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

2.  Fiscal externalities of becoming a parent.

Authors:  Douglas A Wolf; Ronald D Lee; Timothy Miller; Gretchen Donehower; Alexandre Genest
Journal:  Popul Dev Rev       Date:  2011

3.  Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Authors:  Michelle L Kurta; Kirsten B Moysich; Joel L Weissfeld; Ada O Youk; Clareann H Bunker; Robert P Edwards; Francesmary Modugno; Roberta B Ness; Brenda Diergaarde
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-15       Impact factor: 4.254

4.  The utility of web mining for epidemiological research: studying the association between parity and cancer risk.

Authors:  Georgia Tourassi; Hong-Jun Yoon; Songhua Xu; Xuesong Han
Journal:  J Am Med Inform Assoc       Date:  2015-11-27       Impact factor: 4.497

5.  Hormonal risk factors and invasive epithelial ovarian cancer risk by parity.

Authors:  C Bodelon; N Wentzensen; S J Schonfeld; K Visvanathan; P Hartge; Y Park; R M Pfeiffer
Journal:  Br J Cancer       Date:  2013-07-02       Impact factor: 7.640

6.  Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries.

Authors:  Wenpeng You; Ian Symonds; Maciej Henneberg
Journal:  J Ovarian Res       Date:  2018-08-16       Impact factor: 4.234

7.  Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.

Authors:  K K Tsilidis; N E Allen; T J Key; L Dossus; A Lukanova; K Bakken; E Lund; A Fournier; K Overvad; L Hansen; A Tjønneland; V Fedirko; S Rinaldi; I Romieu; F Clavel-Chapelon; P Engel; R Kaaks; M Schütze; A Steffen; C Bamia; A Trichopoulou; D Zylis; G Masala; V Pala; R Galasso; R Tumino; C Sacerdote; H B Bueno-de-Mesquita; F J B van Duijnhoven; M G M Braem; N C Onland-Moret; I T Gram; L Rodríguez; N Travier; M-J Sánchez; J M Huerta; E Ardanaz; N Larrañaga; K Jirström; J Manjer; A Idahl; N Ohlson; K-T Khaw; N Wareham; T Mouw; T Norat; E Riboli
Journal:  Br J Cancer       Date:  2011-09-13       Impact factor: 7.640

8.  The impact of a reduced fertility rate on women's health.

Authors:  Jennifer Payne
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

9.  Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea.

Authors:  Boyoung Park; Sohee Park; Hai-Rim Shin; Aesun Shin; Yohwan Yeo; Ji-Yeob Choi; Kyu-Won Jung; Byoung-Gie Kim; Yong-Man Kim; Dong-Young Noh; Sei-Hyun Ahn; Jae Weon Kim; Sokbom Kang; Jae Hoon Kim; Tae Jin Kim; Daehee Kang; Keun-Young Yoo; Sue K Park
Journal:  BMC Cancer       Date:  2016-01-06       Impact factor: 4.430

10.  Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study.

Authors:  Kezia Gaitskell; Jane Green; Kirstin Pirie; Isobel Barnes; Carol Hermon; Gillian K Reeves; Valerie Beral
Journal:  Int J Cancer       Date:  2017-10-12       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.